Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 13, No. 9, 2014, pp. 1503-1510
Bioline Code: pr14206
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 13, No. 9, 2014, pp. 1503-1510
© Copyright 2014 - Tropical Journal of Pharmaceutical Research
Development and Validation of Liquid Chromatography- Mass Spectroscopy/Mass Spectroscopy Method for Quantitative Analysis of Naproxen in Human Plasma after Liquid-Liquid Extraction|
Sahoo, N.K.; Sahu, M.; Rao, P.S. & Ghosh, G.
Purpose: To determine naproxen levels in human plasma using a new liquid chromatography-Mass
spectroscopy/Mass spectroscopy (LC-MS/MS) method that involves a simple and single step extraction
procedure using low-cost reagents.
Method: A novel liquid chromatography–tandem mass spectrometry method for the quantitative
determination of naproxen in human K2-EDTA plasma in negative ion mode was employed and
validated using zidovudine as internal standard (IS). Sample preparation was accomplished by liquidliquid
extraction technique. The eluted samples were chromatographed on Zorbax Eclipse XDB phenyl
4.6 × 75 mm, 3.5 μm column (Agilent Technologies) using a mobile phase consisting of acetonitrile: 20
mM ammonium acetate (90:10 v/v).The injection volume was 15 μL and the total run time was 3.0 min.
The method was validated for all parameters for naproxen.
Results: The method showed selectivity and linearity over a concentration range of 500.1 ng/mL to
100028.5 ng/mL The validation data indicate precision and accuracy of 90 - 110 % and < 15 %),
respectively, as well as recovery (80.63 %), stability (mostly stable) and carryover (0 %).
Conclusion: A rapid and selective LC-MS/MS method for the quantification of naproxen in human
plasma has been developed and can be used in therapeutic drug monitoring of this drug as well as in
bioequivalence studies of the drug.
Naproxen; Therapeutic drug monitoring; Mass spectrometry; Human plasma
Alternative site location: http://www.tjpr.org